Zoë Etter

MEGIN is the global leader for Magnetoencephalography (MEG) Technology. We are experts in detecting and visualizing brain function, working together with clinicians, scientists, and healthcare organizations, as well as other partners to develop, deliver and support our MEG technology. Our technology and its applications transform neuroscience research and clinical decision making to improve people’s health. Our aim is to advance the standard of care for brain health to improve quality of life. Our mission is to build a customer centric organization to enable growth and advance MEG technology. Together with our customers, we will translate research into accessible clinical solutions. Our commitment is to provide an excellent experience to raise the awareness and utilization of MEG for the benefit of patients globally. MEGIN is a global company, with over 30 years of experience developing, installing, and servicing MEG technology. We have employees working across our global headquarters in Finland, the UK, USA, and Japan.